Results 151 to 160 of about 42,220 (210)

Patients on Losartan Have Similar Rates of Manipulation Under Anesthesia After Total Knee Arthroplasty. [PDF]

Cureus
Miltenberg B, Linton A, Abe E, Martinazzi BJ, Furey G, Johns WL, Sherman MB, Purtill JJ, Smith EB.   +8 more
europepmc   +1 more source

Metabolomic Signatures of Physical Function and Functional Trajectories in Older Adults: Insights from the ENRGISE Clinical Trial. [PDF]

Metabolites
Lynch DH, Arbeeva L, Sumner SCJ, Rushing BR, Batsis JA, Nelson AE, Fielding RA.   +6 more
europepmc   +1 more source

A case of bucillamine-induced membranous nephropathy presenting with acute kidney injury and requiring hemodialysis. [PDF]

CEN Case Rep
Otani H, Suwabe T, Oba Y, Mizuno H, Sekine A, Yamanouchi M, Hasegawa E, Kono K, Fujii T, Takazawa Y, Ohashi K, Wada T, Nakano M, Miyabe Y, Hoshino J, Sawa N, Ubara Y.   +16 more
europepmc   +1 more source

Development and Evaluation of 3D-Printed Losartan Potassium Tablets Using Semi-Solid Extrusion: The Effect of Geometry, Drug Loading and Superdisintegrant. [PDF]

Pharmaceuticals (Basel)
Vojinović A, Medarević Đ, Stanojević G, Mirković D, Mugoša S, Adamov I, Ibrić S.   +6 more
europepmc   +1 more source

Obesity exacerbates experimental colitis due to the activation of the local renin-angiotensin system in the colon. [PDF]

Sci Rep
Pan M, Xu Q, Huang L, Bai Y, Li X, Tang Y.   +5 more
europepmc   +1 more source

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

New England Journal of Medicine, 2001
Mark E Cooper, Dick de Zeeuw, Giuseppe Remuzzi   +2 more
exaly   +2 more sources

A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19

EClinicalMedicine, 2021
Background The SARS-CoV-2 virus enters cells via Angiotensin-converting enzyme 2 (ACE2), disrupting the renin-angiotensin-aldosterone axis, potentially contributing to lung injury.
Michael A Puskarich, Nathan W Cummins, Nicholas E Ingraham   +2 more
exaly   +2 more sources

Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome

Science, 2006
Daniel P Judge, Bart L Loeys, Marc K Halushka   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Losartan

Drugs, 2003
Losartan is an orally active, selective, nonpeptide, angiotensin II AT(1) receptor antagonist. Losartan 50 or 100 mg/day was significantly more effective than placebo in reducing the incidence of a doubling of serum creatinine, end-stage renal disease (ESRD) or death (43.5% vs 47.1%, p = 0.02) in a pivotal, well designed trial (Reduction of Endpoints ...
Christopher I, Carswell, Karen L, Goa
  +6 more sources

Topical Losartan: Practical Guidance for Clinical Trials in the Prevention and Treatment of Corneal Scarring Fibrosis and Other Eye Diseases and Disorders

Journal of Ocular Pharmacology and Therapeutics, 2023
Losartan is an angiotensin II receptor blocker (ARB) that impedes transforming growth factor (TGF) beta signaling by inhibiting activation of signal transduction molecule extracellular signal-regulated kinase (ERK).
S. Wilson
semanticscholar   +1 more source